Collectively, our findings demonstrate that TFNAs ameliorate ANIT-induced CLD through activation of the Wnt/β-catenin and ERK1/2 signaling pathways, along with anti-inflammatory and antioxidant effects. This evidence concerns the gene MAPK3 and congenital secretory chloride diarrhea 1.